Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis
- 1 August 2014
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 143 (2), 181-196
- https://doi.org/10.1016/j.pharmthera.2014.02.013
Abstract
No abstract availableKeywords
Funding Information
- Research Foundation—Flanders (‘Fonds Wetenschappelijk onderzoek Vlaanderen—FWO’ (1.5.060.13N)
This publication has 170 references indexed in Scilit:
- Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vesselsThe International Journal of Biochemistry & Cell Biology, 2013
- Compressive elasticity of three-dimensional nanofiber matrix directs mesenchymal stem cell differentiation to vascular cells with endothelial or smooth muscle cell markersActa Biomaterialia, 2012
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Mesenchymal stem cells engineered for cancer therapyAdvanced Drug Delivery Reviews, 2011
- Mechanical stimuli differentially control stem cell behavior: morphology, proliferation, and differentiationBiomechanics and Modeling in Mechanobiology, 2011
- Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanismsAngiogenesis, 2010
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?The International Journal of Cell Cloning, 2010
- Mesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryAdvanced Drug Delivery Reviews, 2010
- Secretome from mesenchymal stem cells induces angiogenesis via Cyr61Journal of Cellular Physiology, 2009
- Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing miceThe Journal of Gene Medicine, 2008